These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28954266)

  • 21. Effective modified conservative tissue preserving protocol to treat stage I axillary hidradenitis suppurativa: a prospective cohort study of 627 patients with five years follow-up.
    Shirah BH; Shirah HA
    J Dermatolog Treat; 2017 Aug; 28(5):458-463. PubMed ID: 27981857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa.
    Garg A; Besen J; Legler A; Lam CS
    JAMA Dermatol; 2016 May; 152(5):553-7. PubMed ID: 26843464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hidradenitis Suppurativa in Down Syndrome: A Case Series.
    Hamadah I; Haider M; Chisti M; Binamer Y
    Pediatr Dermatol; 2017 Jul; 34(4):461-464. PubMed ID: 28636122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
    Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017.
    Shavit E; Alavi A; Bechara FG; Bennett RG; Bourcier M; Cibotti R; Daveluy S; Frew JW; Garg A; Hamzavi I; Hoffman LK; Hsaio J; Kirby JS; Lev-Tov H; Martinez E; Micheletti R; Naik HB; Nassif A; Nicholson C; Parks-Miller A; Patel Z; Piguet V; Ramesh M; Resnik B; Sayed C; Schultz G; Siddiqui A; Tan J; Wortsman X; Lowes MA
    Exp Dermatol; 2019 Jan; 28(1):94-103. PubMed ID: 30484907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laser hair reduction for hidradenitis suppurativa warrants insurance coverage.
    Carrington AE; Vatanchi M; Sivamani R
    Dermatol Online J; 2020 Apr; 26(4):. PubMed ID: 32621692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
    Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
    Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive approach to managing hidradenitis suppurativa patients.
    Collier EK; Hsiao JL; Shi VY; Naik HB
    Int J Dermatol; 2020 Jun; 59(6):744-747. PubMed ID: 32250448
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychophysical aspects of hidradenitis suppurativa.
    Matusiak L; Bieniek A; Szepietowski JC
    Acta Derm Venereol; 2010 May; 90(3):264-8. PubMed ID: 20526543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidradenitis Suppurativa: The Disease Which Stimulates Researchers and Clinicians.
    Szepietowski JC; Matusiak Ł
    Dermatology; 2020; 236(1):5-7. PubMed ID: 31955165
    [No Abstract]   [Full Text] [Related]  

  • 31. Cigarette smoking as a triggering factor of hidradenitis suppurativa.
    König A; Lehmann C; Rompel R; Happle R
    Dermatology; 1999; 198(3):261-4. PubMed ID: 10393449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hidradenitis suppurativa: MRI features in anogenital disease.
    Griffin N; Williams AB; Anderson S; Irving PM; Sanderson J; Desai N; Goh V
    Dis Colon Rectum; 2014 Jun; 57(6):762-71. PubMed ID: 24807602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hidradenitis suppurativa].
    Charúa-Guindic L; Maldonado-Barrón R; Avendaño-Espinosa O; Navarrete-Cruces T; Osorio-Hernández RM; Jiménez-Bobadilla B
    Cir Cir; 2006; 74(4):249-55. PubMed ID: 17022896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hidradenitis suppurativa in children: The Henry Ford experience.
    Braunberger TL; Nicholson CL; Gold L; Nahhas AF; Jacobsen G; Parks-Miller A; Hamzavi IH
    Pediatr Dermatol; 2018 May; 35(3):370-373. PubMed ID: 29575194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Therapy for Patients With Hidradenitis Suppurativa.
    Westerkam LL; Tackett KJ; Sayed CJ
    JAMA Dermatol; 2021 Jun; 157(6):708-711. PubMed ID: 33825849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What happens after a single surgical intervention for hidradenitis suppurativa? A retrospective claims-based analysis.
    Jemec GB; Guérin A; Kaminsky M; Okun M; Sundaram M
    J Med Econ; 2016 Jul; 19(7):710-7. PubMed ID: 26938967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of our care.
    Graber EM; Burns LR
    JAMA Dermatol; 2014 Sep; 150(9):935-6. PubMed ID: 24908077
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
    Kucinskiene V; Jariene V; Valiukeviciene S
    Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit.
    Wang CX; Buss JL; Keller M; Anadkat MJ
    JAMA Dermatol; 2022 Dec; 158(12):1378-1386. PubMed ID: 36287553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences Between Children and Adults With Hidradenitis Suppurativa.
    Hallock KK; Mizerak MR; Dempsey A; Maczuga S; Kirby JS
    JAMA Dermatol; 2021 Sep; 157(9):1095-1101. PubMed ID: 34379074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.